AstraZeneca’s Covid-19 Antibody Treatment Failed To Prevent Symptoms In Exposed Individuals

AstraZeneca on Tuesday announced its monoclonal antibody treatment for Covid-19 did not meet the primary goal of preventing symptoms in people who have been exposed to the coronavirus, denting hopes of a new therapeutic treatment for Covid-19 for unvaccinated people....

The antibody therapy, however, was 92% effective in preventing symptomatic Covid-19 compared to the placebo in patients who tested negative after exposure, suggesting that the drug may be effective in preventing symptoms in people who are not already infected. The drug continues to be tested as possible prophylaxis against Covid-19 in other trials, the company noted.The trial’s principal investigator, Dr. Myron J.

Which vaccine company you are promoting Forbes?

Key sentence “in people who have been exposed to the coronavirus”

ShoesRudi For a very long moment I thought that a was reading 2020 news of the test results. But these are current news .

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

What to Know About Vitamin D and COVID-19One study found that high levels of vitamin D might lower your risk for severe COVID-19 infection, but how much can it help? What we know so far: In March 2020 medical professionals knew this (as well as other options) but were being barred by health institutions from speaking out about it. Mine told me anyway. 😌 First it does, then it doesn’t. Now it does again. This sort of vacillation feeds the anti-vaxxer frenzy.
Source: WebMD - 🏆 709. / 51 Read more »